AFP — AFT Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- AU$389.31m
- AU$423.75m
- NZ$254.71m
Australia Stock Exchange release from AFT PHARMACEUTIC : PRE_NR Ends: 07:42:56
Australia Stock Exchange release from AFT PHARMACEUTIC : Maxigesic IV registered in the UK and Ireland
Australia Stock Exchange release from AFT PHARMACEUTIC : half year interim results announcement 18 Nov 2021
Australia Stock Exchange release from AFT PHARM : AFT further extends Maxigesic footprint strengthens EU
Australia Stock Exchange release from AFT PHARM : Change of Capital notice
Australia Stock Exchange release from AFT PHARM : Application for quotation of securities - AFP
Australia Stock Exchange release from AFT PHARM : D&O Ongoing Disclosure - Louise Clayton
Australia Stock Exchange release from AFT PHARM : Capital Change Notice - Issue of ordinary shares
Australia Stock Exchange release from AFT PHARM : Maxigesic Oral Liquid gets first regulatory approval
Australia Stock Exchange release from AFT PHARM : Maxigesic IV launches in Germany and Austria
Australia Stock Exchange release from AFT PHARM : ASM 2021 Proxy form
Australia Stock Exchange release from AFT PHARM : Notice of Annual Meeting of Shareholders 2021
Australia Stock Exchange release from AFT PHARM : Application for quotation of securities - AFP
Australia Stock Exchange release from AFT PHARM : Appendix 2A
Australia Stock Exchange release from AFT PHARM : Capital Change Notice
Australia Stock Exchange release from AFT PHARM : FY 2021 AFT Financial Presentation
Australia Stock Exchange release from AFT PHARM : PRE_NR Ends: 07:42:40
Australia Stock Exchange release from AFT PHARM : FY2021 Annual Report
Australia Stock Exchange release from AFT PHARM : FY2021 Announcement App 2